The Non-Insured Health Benefits (NIHB) program establishes exemplary coverage for Dexcom’s real-time continuous glucose monitoring system – bringing game-changing technology to more First Nations and ...

Dexcom G6 was the first Continuous Glucose Monitoring (CGM) System to be officially listed by the NIHB Drug Benefit program. BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), ...

Dexcom’s G6 Continuous Glucose Monitoring system will soon be integrated with Livongo’s platform, thanks to a new partnership between the two diabetes-focused companies. G6 users who are also Livongo ...

When it comes to the diabetes space, Dexcom is one of the heavy hitters. Its work in the continuous glucose monitoring space has put it on the map. In 2018, its Dexcom G6, an integrated continuous ...

Dexcom CGM to become a core part of Livongo’s solution for delivering personalized health insights and improved clinical outcomes to people with Diabetes MOUNTAIN VIEW, Calif. and SAN DIEGO, Jan. 13, ...

DexCom, Inc.DXCM announced that its next generation G6 CGM system has received an approval from Health Canada, a regulatory authority. The device is designed to cater to diabetes patients in Canada, ...

Dexcom, Inc., a leader in continuous glucose monitoring (CGM), announced today that the company has received CE Mark for its Dexcom G6 System for people with diabetes ages two years and up. "The ...

The Australian government has expanded the subsidised access to the latest generation of Dexcom's continuous glucose monitoring device, Dexcom G6, for diabetic Australians. This comes as the previous ...